Roche Holding AG - Operating Return On Assets
Roche Holding AG's Fiscal Year is From January To December - All Figures are in Percent.
The item "Operating-Return-On-Assets" stands at 26.87 percent as of 06/30/2025, the lowest value at least since 03/31/2022, the period currently displayed.
As of the end of Roche Holding AG's second quarter, the item "Operating Return On Assets" stands at 26.87 Percent. This represents a decrease of -11.36 percentage points compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -11.22 percentage points compared to the value the year prior.
The 1 year change in percentage points is -11.22.
The 3 year change in percentage points is -14.06.
The Serie's change in percentage points from it's minimum value, on 06/30/2025, to it's latest available value, on 06/30/2025, is +0.0.
The Serie's change in percentage points from it's maximum value, on 06/30/2022, to it's latest available value, on 06/30/2025, is -14.06.
Operating Return On Assets for Related Companies:
| Logo | Name | Market Cap (USD) |
|---|---|---|
 | Eli Lilly and Company - Operating Return On Assets | 905,699,262,464.00 |
 | Johnson & Johnson - Operating Return On Assets | 486,508,953,600.00 |
 | AbbVie Inc - Operating Return On Assets | 399,570,305,024.00 |
 | AstraZeneca PLC - Operating Return On Assets | 280,205,508,085.11 |
 | Novartis AG - Operating Return On Assets | 255,096,620,580.91 |